WO2000063388A1 - Nouvelle aspartokinase desensibilisee - Google Patents
Nouvelle aspartokinase desensibilisee Download PDFInfo
- Publication number
- WO2000063388A1 WO2000063388A1 PCT/JP2000/002456 JP0002456W WO0063388A1 WO 2000063388 A1 WO2000063388 A1 WO 2000063388A1 JP 0002456 W JP0002456 W JP 0002456W WO 0063388 A1 WO0063388 A1 WO 0063388A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- lysine
- coryneform bacterium
- amino acid
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
Definitions
- the present invention relates to a novel aspartokinase derived from a coryneform bacterium, which encodes the enzyme
- the present invention relates to a method for producing L-lysine. Scenic fe
- the following method is known as a method for producing L-lysine by fermentation using a microorganism belonging to the genus Corynepacterium.
- L-lysine-producing mutant for example, S- (2-aminoethyl) -cystine (hereinafter abbreviated as AEC) resistant mutant (amino acid fermentation, 1986, p. 273, Gakkai Shuppan Center) ), L-homoserine-requiring mutant (amino acid fermentation, 1986, p. 273, Gakkai Shuppan Sen-ichi), respiratory inhibitor-resistant mutant (Tokuhei 5-55114), pyrimidine analog-resistant mutant (Japanese Unexamined Patent Publication No. -88094) and purine analog-resistant mutants (JP-B-63-062199) are known.
- AEC S- (2-aminoethyl) -cystine
- AK aspartokinase
- desensitized AK Mutant AK from which this feedback inhibition has been released (hereinafter abbreviated as desensitized AK) is It is known that microorganisms belonging to the genus Corynepacterium that carry a gene (hereinafter abbreviated as desensitized AK gene) secrete L-lysine outside the cells (amino acid fermentation, 1986 , P. 273, Academic Publishing Center).
- the wild-type gene can be mutated by combining it with a technique that converts the nucleotide sequence to the desired one in a test tube (for example, using the Strak Gene QuikChange site-directed mugenesis kit). Can be converted to a type.
- a technique that converts the nucleotide sequence to the desired one in a test tube for example, using the Strak Gene QuikChange site-directed mugenesis kit.
- An object of the present invention is to convert AK, a key enzyme of L-lysine biosynthesis in coryneform bacteria, to a desensitized form which is released from concerted feedback inhibition by L-lysine and L-threonine and feedback inhibition by lysine alone. It should be modified to make it advantageous for L_lysine production.
- the present inventors have conducted intensive studies on an efficient method for producing L-lysine by coryneform bacteria, and found that L-lysine and L-threonine have released concerted feedback inhibition, and that L-lysine alone can be used as a filter.
- the present inventors have found that a strain having a desensitized AK from which debac inhibition has been released has excellent L-lysine-producing ability, and completed the present invention.
- the present invention relates to the following (1) to (12).
- coryneform bacterium is a genus Corynebacterium or Brevibacterium
- a recombinant DNA capable of being replicated in a coryneform bacterium obtained by incorporating any one of the above DNAs (1) to (3) into a vector.
- a microorganism or a transformant selected from the coryneform bacterium of the above (5) and the transformant of the above (6) and (7) is cultured in a medium, and L-lysine is produced and accumulated in the culture.
- a method for producing L-lysine comprising collecting L-lysine from the culture.
- a DNA encoding aspartokinase which is derived from a coryneform bacterium and has a base sequence in which the amino acid residue at position 31 in the amino acid sequence of SEQ ID NO: 18 is Thr.
- a DNA encoding the aspartokinase of the above (1) can be prepared.
- the microorganism that supplies the DNA containing the gene encoding AK may be any microorganism that belongs to coryneform bacteria and has AK activity. No.
- Examples of the coryneform bacterium in the present invention include the genus Agrococcus, the genus Agromyces, the genus Arthrobacter, the genus Aureobacterium, and the genus Levibacterium.
- Preferable examples include bacteria belonging to the genus Corynebacterium and the genus Brevipacterium. As specific examples, for example, the following strains are used.
- Corynebacterium guru mimic ATCC13032 Corynebacterium guru mimic ATCC13869 Corynebacterium guru micam ATCC13870 Corynebacterium carnae ATCC15991 Corynebacterium acetoglu micam ATCC15806.
- the wild-type strain supplies the wild-type AK gene, which is subject to feedback inhibition by L-lysine or L-lysine and L-threonine.
- a mutation operation from a wild-type strain for example, N-methyl- ⁇ '-nitro --- ⁇ Method using torsogazine (NTG); Microbial Experiment Manual, 1986, p. 131, Kodansha Scientific Inc.
- mutants include L-lysine-producing bacteria induced by mutation treatment from the wild-type strain of C.
- glutamicum ATCC13032 or the wild-type ⁇ gene
- NTG method or the in vitro mutation method eg, hydroxyl A method using an amine; including a desensitized AK gene, which is induced by mutation in the gene by Molecular and General Genetics, 145, 101 (1978), and is desensitized using AEC resistance and L-lysine productivity as an index. Stocks, etc. can be given.
- the AK gene was obtained from a strain containing the AK gene, for example, by the method of Saito et al. [Biochimica et Biophysica Acta, 72, 619 (1963)]. That is, chromosomal DNA is prepared and cut with an appropriate restriction enzyme. After cleavage, the obtained fragment is ligated to a vector (for example, plasmid) capable of autonomous replication in the microorganism, and this is introduced into a host microorganism lacking AK activity. It can be obtained by isolating a transformant capable of expressing AK activity from the microorganism and isolating the gene from the transformant.
- a vector for example, plasmid
- any microorganism that can express the AK gene of a coryneform bacterium can be used.
- Preferable is an AK-deficient strain of Escherichia coli.
- Any vector capable of autonomous replication can be used as long as it can autonomously replicate in a microorganism into which the vector has been introduced.
- pUC18 Takara Shuzo
- One vector such as pBluescriptSK (-) (manufactured by Toyobo), is a vector that can replicate autonomously in Escherichia coli, and a vector, such as pCE54 (Japanese Patent Application Laid-Open No. 58-105999), is a vector that can replicate autonomously in both Escherichia coli and coryneform bacteria. be able to.
- pBluescriptSK manufactured by Toyobo
- pCE54 Japanese Patent Application Laid-Open No. 58-105999
- Ligation of the vector and the DNA fragment containing the AK gene can be performed by a usual method using T4 DNA ligase or the like.
- introduction into a host can be performed by the method of Hanahan et al. [Journal of Molecular Biology, 166, 557 (1983)].
- the AK gene can be isolated and obtained by the following method.
- Oligomeric DNA was synthesized based on the already known base sequence information of the AK gene derived from Corynebacterium gullica micam [eg, GenBank Accession No. E06825], and the DM was used as a primer, A DNA fragment containing the gene is amplified and isolated by PCR. The DNA fragment is ligated to a vector having a selectable marker gene and introduced into an appropriate host microorganism such as Escherichia coli or coryneform bacterium. The AK gene can be obtained by isolating the vector introduced from the microorganism. It is not necessary to use an AK-deficient strain for the host microorganism.
- any vector can be used as long as it can replicate autonomously in coryneform bacterium. May be.
- pCGl JP-A-57-134500
- pCG2 JP-A-58-35197
- PCG4 JP-A-57-183799
- pCGll JP-A-57-134500
- pCG116 pCE54
- pCBlOl All of which are JP-A-58-105999
- pCE51, pCE52, pCE53 [Molecular and General Genetics, 196, 175 (1984)]
- pCS299P showing the production process in the present invention.
- those having a relatively small size such as pCG116 and pCS299P, having many closing sites, and having a selectable marker gene such as a drug resistance gene are used.
- Methods for introducing the above recombinant DNA into coryneform bacteria include the protoplast method (for example, JP-A-57-186492 and JP-A-57-18649), electroporation [for example, Journal of Bacteriology, 175, 4096]. (1993)].
- the coryneform bacterium having the DNA encoding the novel AK of the present invention on the chromosome may be any coryneform bacterium containing the AK gene on the chromosome.
- microorganisms having the DNA fragment artificially inserted into the chromosome can be mentioned by, for example, “Society 1” for “Micro mouth biology”.
- L-lysine By culturing the transformed strain belonging to the coryneform bacterium having the DNA containing the novel AK gene obtained as described above, L-lysine can be produced and accumulated in the culture solution.
- an ordinary nutrient medium containing a carbon source, a nitrogen source, inorganic salts and the like can be used as a culture medium.
- sugars such as glucose, fructose, sucrose, maltose, and starch hydrolysate, alcohols such as ethanol, and organic acids such as acetic acid, lactic acid, and succinic acid can be used.
- Nitrogen sources include various inorganic and organic ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, ammonium carbonate, and ammonium acetate, urea, Other nitrogen-containing compounds and nitrogen-containing organic substances such as meat extract, yeast extract, corn 'steep' liquor, and soybean hydrolyzate can be used.
- the inorganic salts there can be used dihydrogen phosphate phosphate, dihydrogen phosphate phosphate, ammonium sulfate, sodium chloride, magnesium sulfate, calcium carbonate, and the like.
- trace nutrients such as biotin and thiamine can be added as needed.
- These micronutrients can also be replaced by media additives such as meat extract, yeast extract, corn 'steep' liquor, casamino acids and the like.
- Cultivation is performed under aerobic conditions such as shaking culture and deep aeration stirring culture.
- the culture temperature is preferably 20 to 40 ° C.
- the pH in the medium is preferably maintained near neutrality.
- the pH is adjusted using inorganic or organic acids, alkaline solutions, urea, calcium carbonate, ammonia and the like.
- the culture period is usually 1 to 6 days.
- L-Lysine can be recovered from the resulting culture by a known method such as activated carbon treatment or ion exchange resin treatment.
- Fig. 1 is a diagram showing the construction process of PCS299P. BEST MODE FOR CARRYING OUT THE INVENTION
- Shuttle plasmid PCS299P capable of autonomous replication in both Escherichia coli and coryneform bacteria was prepared by the following method.
- PCG116 Bio / Technology, 11, 921 (1993) was cut with (manufactured by Takara Shuzo) to obtain an il digested fragment.
- the strain was added to 10 g of LB agar medium containing 20 g / ml kanamycin [Pactotryptone (Difco), 5 g of yeast extract (Difco), 10 g of sodium chloride, and 16 g of Pactagar (Difco) in water. On a medium containing 1 L and adjusted to pH 7.0] to select a transformant. The transformant was cultured overnight in an LB medium containing 20 zg / ml kanamycin, and a plasmid was prepared from the obtained culture solution by the alkaline SDS method (Molecular- 1 'Cloning 2nd edition). pCS116-299Bgll DNA was obtained.
- the restriction enzyme cleavage site of PCS116-299Bgll was confirmed by a conventional method.
- Corynepterium and ammoniagenes ATCC6872 were transformed by electroporation using pCS116-299Bgll DNA [FEMS Microbiology Letters, 65, 299, (1989)].
- a plasmid was extracted from the transformant in a conventional manner, and the plasmid was cleaved with a restriction enzyme to confirm that the plasmid was pCS116-299Bgll.
- pCS116-299Bgll DNA was digested with ⁇ 1 (Takara Shuzo) and ⁇ 11 and purified by ethanol precipitation.
- a partially deleted plasmid was obtained from the obtained DNA using a deletion kit for kilosequencing (Takara Shuzo).
- Escherichia coli NM522 was transformed according to a conventional method.
- the strain was cultured on an LB agar medium containing 20 g / ml kanamycin, and a transformant was selected.
- the transformant was cultured overnight in an LB medium containing 20 ⁇ g / ml: Plasmid was prepared by the method. Restriction enzyme maps of each of the obtained plasmids were prepared according to a conventional method, and plasmids having different partial deletion lengths were selected.
- the selected plasmid was used to transform Corynebacterium 'Ammoniagenes ATCC6872 by electroporation.
- the resulting transformant is spread on a CM agar medium containing 20 zg / ml kanamycin and cultured at 30 ° C for 2 days.
- Corynepacteria ammonia ammoniagenes is used as an index based on the appearance of kanamycin resistant colonies.
- a plasmid capable of autonomous replication was selected.
- the plasmid having the longest deletion region among the plasmids having autonomous replication ability was selected, and this plasmid was designated as pCS299del6.
- pCS299del6 DNA was prepared from the transformant according to a conventional method, it was cleaved with restriction enzymes ⁇ pI and PvuH (both from Takara Shuzo). After fractionating the cleaved DNA fragment by agarose gel electrophoresis, an approximately 2.7 kb MA fragment having DNA derived from pCG116 was separated and extracted and purified using DNAprep (manufactured by Asahi Glass Co., Ltd.).
- pBluescript SK (+) (Toyobo Co., Ltd.) DNA was cut with ⁇ RV (Takara Shuzo) according to a conventional method. The obtained cut DNA fragment was concentrated by an ethanol precipitation method, and then treated with alkaline phosphatase. The treated DNA fragment was fractionated by agarose gel electrophoresis, and extracted and purified using DNA prep.
- the ligated DNA was used to transform Escherichia coli NM522 according to a conventional method.
- the strain was treated with 100 ⁇ g / ml of ampicillin, 50 ⁇ g / ml of X-Gal (5-bromo-4-chloro-3-indoyl-? -D-galactoside), and 1 ol / l of IPTG (isopropylthio- Transformants were selected by culturing on LB agar medium containing ⁇ -D-galactoside).
- the transformant was cultured overnight in an LB medium containing 100 ⁇ g / ml of ampicillin, and a plasmid was prepared from the resulting culture by the Arikari SDS method. Restriction enzyme maps of the obtained plasmids were prepared according to a conventional method.
- the plasmid that generates fragments of 3.4 kb and 2 kb by ⁇ RI digestion was designated PCSSK21.
- the DNAs shown in SEQ ID NOS: 1 and 2 were synthesized, and these DNAs were used as primers for pHSG299 DNA.
- the PCR reaction was performed using Taq DNA polymerase (Takara Shuzo Co., Ltd.) according to the attached reaction conditions. After the reaction product was precipitated with ethanol according to a conventional method, it was cleaved with restriction enzymes ⁇ 1 and ⁇ I (Takara Shuzo). The cleaved DNA fragment was fractionated by agarose gel electrophoresis, and the obtained DNA fragment of about 1.3 kb was extracted and purified using DNA prep.
- the DNAs shown in SEQ ID NOS: 3 and 4 were synthesized, and PCR was performed using these DNAs as primers, pHSG299 DNA as type III, and Taq DNA polymerase according to the attached reaction conditions.
- the reaction product was precipitated with ethanol according to a conventional method, and then cleaved with restriction enzymes l and il.
- the cleaved DNA fragment was fractionated by agarose gel electrophoresis, and the obtained DNA fragment of about 1.3 kb was extracted and purified using DNA prep.
- the plasmid PCSSK21 obtained above was cut using ⁇ II (manufactured by Takara Shuzo) and each other.
- the cleaved DNA fragment was fractionated by agarose gel electrophoresis, and the obtained DNA fragment of about 2.7 kb was extracted and purified using DNA prep. After mixing and purifying the above three types of MA fragments extracted and purified, they were ligated using a ligation kit ver.
- Escherichia coli NM522 was transformed according to a conventional method.
- the strain was cultured on an LB agar medium containing 20 ⁇ g / ml of kanamycin, 50 ⁇ g / ml of X-Gal, and 1 ol / l of IPTG, and a transformant was selected.
- the transformant was cultured overnight in an LB medium containing 20 g / ml kanamycin, and a plasmid was prepared from the resulting culture by the alkaline SDS method.
- a restriction map of each of the obtained plasmids was prepared according to a conventional method, and the plasmid having the structure shown in FIG. 1 was designated as PCS299P.
- Example 2 Production of mutant strain producing L-lysine and nucleotide sequence determination of AK gene derived from the strain Mutant treatment of Corynebacterium glutamicum wild-type strain (ATCC13032) with NTG (Microbial Experiment Manual, 1986, p.
- the appearing colony was isolated, and a production test of L-lysine was performed by the method described in Example 5 described later, and a clone having improved productivity was selected. From one of the strains (AEC11 strain) and the wild-type strain ATCC13032, the AK gene was amplified by PCR as follows, and the nucleotide sequence was determined.
- Chromosomal DNA was prepared from each strain by the method of Saito et al. [Biochimica et Biophysica Acta, 72, 619 (1963)].
- a DNA primer for amplification was designed based on the nucleotide sequence of the AK gene [GenBank, Accession No. E06825], which is known in Corynebacterium 'Guruya micum ATCC13869 strain. The DNA primers are shown in SEQ ID NOS: 5 and 6.
- PCR was carried out using a DNA polymerase derived from Phyrococcus sp. KOD strain (manufactured by Toyobo Co., Ltd.) and the attached buffer. PCR was performed for 30 cycles, with the reaction at 94 ° C for 30 seconds, 60 ° C for 30 seconds, and 74 ° C for 60 seconds as one cycle.
- the amplified DNA of about 1.5 Kb was purified using a PCR product sequencing kit (manufactured by Amersham-Pharmacia), and the purified DNA was subjected to cycle sequencing.
- the DNA primer used for the sequencing reaction was designed based on the above AK gene base sequence. The DNA primers are shown in SEQ ID NOs: 7 to 16.
- ABI Prism Die 'Yuichi Mine Ichiichi' Cycle Sequencing 'Lady's Reaction' Kit (PerkinElmer), 96 ° C-10 seconds, 50 ° C-5 seconds, A 25-cycle sequence reaction was performed using a reaction at 60 ° C. for 4 minutes as one cycle, and the nucleotide sequence was determined by ABI Prism 377 DNA Sequencing 'System (manufactured by Pachinkin Pharma Co., Ltd.).
- SEQ ID NOS: 17 and 18 show the nucleotide sequence of the mutant AK gene derived from the AEC11 strain and the amino acid sequence of the corresponding open reading frame.
- thymine at position 932 is Then it was cytosine.
- the L-threonine residue at position 311 (codon ACC) of wild-type AK was replaced with an isoleucine residue (codon ATC) in the AK gene derived from the AEC11 strain.
- Examples of the desensitizing mutation of the AK gene of Corynebacterium glutamicum include mutation of Ala279 to an amino acid other than Ala (JP-A-6-62866, JP-A-6-261766), Gly345Asp [Journal of Bacteriology, 175, 4096 ( 1993)], Ser301Tyr [Molecular Microbiology, 5, 1197 (1991)], Ser301Phe, Thr308Ile (all disclosed in JP-A-6-261766), etc., but this mutation did not correspond to any of them.
- the AK gene was cloned from Corynebacterium glutamicum wild-type strain (ATCC13032) and L-lysine-producing AEC11 strain by PCR.
- a 1.5 Kb gene fragment containing the AK gene derived from the ATCC13032 strain or the AEC11 strain obtained in the same manner as in Example 2 was treated with I and BamHI (Takara Shuzo), and then subjected to agarose electrophoresis. It was cut out from the gel and purified using Gene 'Clean' kit (BI0101).
- Shuttle vector PCS299P capable of autonomous growth in both Escherichia coli and coryneform bacterium shown in Example 1 was cut with ⁇ 1 and ⁇ ⁇ ⁇ , and the Reigeshon kit ver. L (Takara Shuzo) was used to ligate to the above AK gene fragment.
- Escherichia coli DH5 strain manufactured by Toyobo Co., Ltd.
- was transformed according to the attached manual and colonies growing on an LB agar medium containing 100 / g / ml of ampicillin were isolated. These colonies were cultured, and plasmid DNA was prepared in the same manner as in Example 1.
- the nucleotide sequence was determined by the method described in Example 2, and a clone containing no mutation in the PCR process was selected.
- One of the plasmids containing the AK gene derived from the ATCC13032 strain obtained by the selection was named pAKl, and the plasmid containing the AK gene derived from the AECll strain was named pAK2.
- pAKl One of the plasmids containing the AK gene derived from the ATCC13032 strain obtained by the selection
- pAK2 the plasmid containing the AK gene derived from the AECll strain was named pAK2.
- Plasmids ⁇ 1, pAK2 and PCS299P were introduced into Corynebacterium gullimicum wild-type strain ATCC13032 by electroporation [FEMS Microbiology Letters, 65, 299 (1989)].
- the resulting strain carrying the plasmid pAK1 was designated as Tf-14, the strain carrying pAK2 as Tf-5, and the strain carrying pCS299PII as Tf-21.
- the AK activity of these transformants was measured by the method of Foretty et al. [Journal of Bacteriology, 175, 4096 (1993)].
- Table 1 shows the AK specific activity of the crude extract of the transformant.
- Tf-5 not only lost the concerted inhibition by L-lysine and L-threonine, but also significantly released the feedback inhibition by L-lysine.
- Tf-5 was deposited at the Research Institute of Biotechnology, Institute of Biotechnology, Ministry of International Trade and Industry (1-3 1-3 Tsukuba-Higashi, Ibaraki, Japan) under the deposit number: FERM BP-6689 on April 2, 2001 Have been.
- Example 5 Corynepac Effect of mutant AK on L-lysine production in Terium glutamicum The L-lysine-producing ability of Tf-5, Tf-14 and Tf-21 produced in Example 4 was evaluated by culture.
- Each strain was seeded with a seed medium (50 g sucrose, 30 g soy hydrolyzate, 3 g urea, 20 g peptone, 20 g strength amino acid, 20 g meat extract, 0.5 g magnesium sulfate heptahydrate, 2 g potassium dihydrogen phosphate) , Ammonium sulfate 8g, thiamine 'hydrochloride lmg, piotin 0.1mg, pantothenate 10mg, ferrous sulfate heptahydrate 10ing, zinc sulfate heptahydrate lmg, nicotinic acid 20mg and calcium carbonate 10g in water 1 L. pH 7.2) 5 ml was inoculated and cultured at 30 ° C for 16 hours with shaking.
- a seed medium 50 g sucrose, 30 g soy hydrolyzate, 3 g urea, 20 g peptone, 20 g strength amino acid, 20 g meat extract
- 1 ml of the seed culture obtained in this culture was used for main culture medium (moisture molasses 200 g, ammonium sulfate 45 g, urea lg, monopotassium dihydrogen phosphate 0.5 g, magnesium sulfate heptahydrate 0.5 g, biotin 0.3 mg and calcium carbonate).
- 30 g was contained in 1 L of water, pH 7.0), and inoculated into 10 ml, followed by shaking culture at 30 ° C for 72 hours.
- Quantification of L-lysine accumulated in the medium was performed by high-performance liquid chromatography.
- AK which is a key enzyme of L-lysine biosynthesis in coryneform bacteria, is modified to a desensitized type which is released from concerted feedback inhibition by L-lysine and L-threonine and feedback inhibition by lysine alone. This can be advantageous for the production of L-lysine.
- SEQ ID NO: 2 Description of artificial sequence-Synthetic DNA
- SEQ ID NO: 4 Description of artificial sequence-Synthetic DNA
- SEQ ID NO: 7 Description of artificial sequence—Synthetic DNA
- SEQ ID NO: 8 Description of artificial sequence-Synthetic DNA
- SEQ ID NO: 10 Description of artificial sequence-One synthetic DNA
- SEQ ID NO: 11 Description of artificial sequence-Synthetic DNA
- SEQ ID NO: 12 Description of artificial sequence-synthetic DNA
- SEQ ID NO: 13 Description of artificial sequence-synthetic DNA
- SEQ ID NO: 14 Description of artificial sequence-synthetic DNA
- SEQ ID NO: 15 Description of artificial sequence-synthetic DNA
- SEQ ID 16 Description of artificial sequence-Synthetic DNA
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00917314A EP1172437B1 (en) | 1999-04-19 | 2000-04-14 | Novel desensitized aspartokinase |
MXPA01010413A MXPA01010413A (es) | 1999-04-19 | 2000-04-14 | Aspartoquinasa desensibilizada novedosa. |
KR1020017013302A KR100671785B1 (ko) | 1999-04-19 | 2000-04-14 | 신규한 탈감작형 아스파르토키나아제 |
JP2000612467A JP4526710B2 (ja) | 1999-04-19 | 2000-04-14 | 新規な脱感作型アスパルトキナーゼ |
AU38374/00A AU3837400A (en) | 1999-04-19 | 2000-04-14 | Novel desensitized aspartokinase |
US09/958,606 US6893848B1 (en) | 1999-04-19 | 2000-04-14 | Desensitized aspartokinase |
AT00917314T ATE510917T1 (de) | 1999-04-19 | 2000-04-14 | Desensibilisierte aspartokinase |
HK02104011.5A HK1042321B (zh) | 1999-04-19 | 2002-05-29 | 新型脫敏型天冬氨酸激酶 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11043799 | 1999-04-19 | ||
JP11/110437 | 1999-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000063388A1 true WO2000063388A1 (fr) | 2000-10-26 |
Family
ID=14535714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/002456 WO2000063388A1 (fr) | 1999-04-19 | 2000-04-14 | Nouvelle aspartokinase desensibilisee |
Country Status (10)
Country | Link |
---|---|
US (1) | US6893848B1 (ja) |
EP (1) | EP1172437B1 (ja) |
JP (1) | JP4526710B2 (ja) |
KR (1) | KR100671785B1 (ja) |
CN (1) | CN100540668C (ja) |
AT (1) | ATE510917T1 (ja) |
AU (1) | AU3837400A (ja) |
HK (1) | HK1042321B (ja) |
MX (1) | MXPA01010413A (ja) |
WO (1) | WO2000063388A1 (ja) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003040373A2 (en) * | 2001-08-06 | 2003-05-15 | Degussa Ag | Production of l-lysine by genetically modified corynebacterium glutamicum strains |
US6927046B1 (en) | 1999-12-30 | 2005-08-09 | Archer-Daniels-Midland Company | Increased lysine production by gene amplification using coryneform bacteria |
US7083942B2 (en) | 2002-03-09 | 2006-08-01 | Degussa Ag | Alleles of the aceA gene from coryneform bacteria |
US7160711B2 (en) | 2001-08-06 | 2007-01-09 | Degussa Ag | Coryneform bacteria which produce chemical compounds I |
WO2007063866A1 (ja) | 2005-11-29 | 2007-06-07 | Kyowa Hakko Kogyo Co., Ltd. | 新規蛋白質および該蛋白質をコードするdna |
WO2007074857A1 (ja) | 2005-12-27 | 2007-07-05 | Kyowa Hakko Kogyo Co., Ltd. | L-グルタミンの製造法 |
US7566557B2 (en) | 2003-12-18 | 2009-07-28 | Paik Kwang Industrial Co., Ltd. | Gene variants coding for proteins from the metabolic pathway of fine chemicals |
JP2009531042A (ja) * | 2006-03-30 | 2009-09-03 | ビーエーエスエフ ソシエタス・ヨーロピア | カダベリンの生産方法 |
DE102008001874A1 (de) | 2008-05-20 | 2009-11-26 | Evonik Degussa Gmbh | Verfahren zur Herstellung von L-Aminosäuren |
JP2009284905A (ja) * | 2009-06-26 | 2009-12-10 | Toray Ind Inc | カダベリン発酵コリネ型細菌を用いたポリアミドの製造方法 |
WO2010005099A1 (ja) | 2008-07-09 | 2010-01-14 | 味の素株式会社 | アミノヒドロキシ安息香酸類の製造方法 |
US20100255544A1 (en) * | 2001-08-06 | 2010-10-07 | Evonik Degussa Gmbh | Coryneform bacteria which produce chemical compounds ii |
JP2011510642A (ja) * | 2008-02-04 | 2011-04-07 | ビーエーエスエフ ソシエタス・ヨーロピア | ジピコリネートの産生方法 |
WO2011073278A1 (en) | 2009-12-17 | 2011-06-23 | Basf Se | Processes and recombinant microorganisms for the production of cadaverine |
US8202706B2 (en) | 2006-07-13 | 2012-06-19 | Evonik Degussa Gmbh | Method of production of L-amino acids |
WO2012114256A1 (en) | 2011-02-22 | 2012-08-30 | Basf Se | Processes and recombinant microorganisms for the production of cadaverine |
WO2013000827A1 (de) | 2011-06-28 | 2013-01-03 | Evonik Degussa Gmbh | Varianten des promotors des für die glyzerinaldehyd-3-phosphat-dehydrogenase kodierenden gap-gens |
EP2612915A1 (en) | 2006-09-01 | 2013-07-10 | Kyowa Hakko Bio Co., Ltd. | Method for production of L-Glutamine |
WO2013179711A1 (ja) | 2012-05-29 | 2013-12-05 | 味の素株式会社 | 3-アセチルアミノ-4-ヒドロキシ安息香酸の製造方法 |
EP2940144A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Lysin unter Verwendung eines alkaliphilen Bakteriums |
EP2940143A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Aminosäuren unter Verwendung eines alkaliphilen Bakteriums |
EP2940039A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Aminosäuren in Corynebakterien unter Verwendung eines Glycin spaltenden Systems |
DE102014208199A1 (de) | 2014-04-30 | 2015-11-05 | Evonik Degussa Gmbh | Verfahren zur Produktion von L-Aminosäuren unter Verwendung eines alkaliphilen Bakteriums |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222503B1 (hu) | 1995-06-07 | 2003-07-28 | Ajinomoto Co., Inc. | Eljárás L-lizin termelésére |
JP4035855B2 (ja) | 1996-06-05 | 2008-01-23 | 味の素株式会社 | L−リジンの製造法 |
MXPA03007089A (es) | 2001-02-08 | 2004-10-15 | Archer Daniels Midland Co | Construccion de polinucleotidos para produccion incrementada de lisina. |
DE10239073A1 (de) * | 2002-08-26 | 2004-03-11 | Basf Ag | Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien |
DE102004011248A1 (de) * | 2004-03-09 | 2005-09-22 | Degussa Ag | Verfahren zur Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien |
US20090029425A1 (en) * | 2006-03-09 | 2009-01-29 | Basf Se | Process for the production of beta-lysine |
EP2386650B1 (en) * | 2006-04-07 | 2013-07-03 | Evonik Degussa GmbH | Method for producing L-amino acids using the gap promoter |
EP1881076A1 (en) * | 2006-07-17 | 2008-01-23 | Evonik Degussa GmbH | Method for producing L-amino acids |
KR101512432B1 (ko) | 2010-06-15 | 2015-04-16 | 백광산업 주식회사 | 미생물을 이용한 아스파테이트 계열 아미노산의 생산방법 |
EP3456833A1 (en) | 2017-09-18 | 2019-03-20 | Evonik Degussa GmbH | Method for the fermentative production of l-amino acids |
EP3467099A1 (en) * | 2017-10-05 | 2019-04-10 | Evonik Degussa GmbH | Method for the fermentative production of l-amino acids |
EP3498853A1 (en) | 2017-12-14 | 2019-06-19 | Evonik Degussa GmbH | Method for the fermentative production of l-lysine |
EP3594355A1 (en) | 2018-07-12 | 2020-01-15 | Evonik Operations GmbH | Method for the fermentative production of l-lysine |
EP3599282B1 (en) | 2018-07-24 | 2021-03-17 | Evonik Operations GmbH | Method for the fermentative production of l-lysine |
RU2019128538A (ru) | 2018-09-26 | 2021-03-11 | Эвоник Оперейшенс ГмбХ | Способ ферментативного получения l-лизина |
EP3660158A1 (en) | 2018-11-29 | 2020-06-03 | Evonik Operations GmbH | Method for the fermentative production of l-lysine |
EP3670525A1 (en) | 2018-12-18 | 2020-06-24 | Evonik Operations GmbH | Method for the fermentative production of l-lysine using c. glutamicum strains with a mutated kup transporter |
US10829746B2 (en) * | 2019-01-23 | 2020-11-10 | Evonik Operations Gmbh | Method for the fermentative production of L-lysine |
WO2021048353A1 (en) | 2019-09-11 | 2021-03-18 | Evonik Operations Gmbh | Coryneform bacteria with a heterologous threonine transporter and their use in the production of l-threonine |
WO2023041425A1 (en) | 2021-09-20 | 2023-03-23 | Evonik Operations Gmbh | Method for the fermentative production of l-lysine using c. glutamicum strains expressing modified gluconate repressor proteins gntr1 and gntr2 |
WO2023222510A1 (en) | 2022-05-18 | 2023-11-23 | Evonik Operations Gmbh | Biotechnological production of desferrioxamines and analogs thereof |
WO2023222505A1 (en) | 2022-05-18 | 2023-11-23 | Evonik Operations Gmbh | Biotechnological production of monomers of bisucaberins, desferrioxamines and analogs thereof |
WO2023222515A1 (en) | 2022-05-18 | 2023-11-23 | Evonik Operations Gmbh | Biotechnological production of bisucaberins, desferrioxamines and analogs thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06261766A (ja) * | 1993-03-16 | 1994-09-20 | Mitsubishi Petrochem Co Ltd | フィードバックインヒビションの解除されたアスパルトキナーゼをコードする遺伝子dna及びその利用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5610036B1 (ja) | 1969-07-23 | 1981-03-05 | ||
JPS5828292A (ja) | 1981-08-10 | 1983-02-19 | Kyowa Hakko Kogyo Co Ltd | 発酵法によるl−リジンの製造法 |
JPS5886094A (ja) | 1981-11-13 | 1983-05-23 | Kyowa Hakko Kogyo Co Ltd | 発酵法によるl−リジンノ製造法 |
US5236831A (en) | 1981-12-29 | 1993-08-17 | Kiowa Hakko Kogyo Co., Ltd. | Amino acid synthesis in corynebacteria using E. coli genes |
JPS5988094A (ja) | 1982-11-10 | 1984-05-21 | Kyowa Hakko Kogyo Co Ltd | 発酵法によるl−リジンの製造法 |
JPH0673318B2 (ja) | 1986-09-02 | 1994-09-14 | 理化学研究所 | マイクロ波導入装置 |
JPH0755155B2 (ja) | 1986-09-10 | 1995-06-14 | 協和醗酵工業株式会社 | アミノ酸の製造法 |
US5096502A (en) | 1990-12-03 | 1992-03-17 | The Babcock & Wilcox Company | Advanced water lance control system based on peak furnace wall emissivity |
JPH0511959A (ja) | 1991-07-04 | 1993-01-22 | Matsushita Electric Ind Co Ltd | マルチウインドウ制御装置 |
JP3473042B2 (ja) | 1992-04-28 | 2003-12-02 | 味の素株式会社 | 変異型アスパルトキナーゼ遺伝子 |
JP2580960B2 (ja) | 1993-08-09 | 1997-02-12 | タイガー魔法瓶株式会社 | 電子レンジの湯沸し制御システム |
-
2000
- 2000-04-14 KR KR1020017013302A patent/KR100671785B1/ko active IP Right Grant
- 2000-04-14 MX MXPA01010413A patent/MXPA01010413A/es active IP Right Grant
- 2000-04-14 JP JP2000612467A patent/JP4526710B2/ja not_active Expired - Lifetime
- 2000-04-14 AT AT00917314T patent/ATE510917T1/de not_active IP Right Cessation
- 2000-04-14 US US09/958,606 patent/US6893848B1/en not_active Expired - Lifetime
- 2000-04-14 AU AU38374/00A patent/AU3837400A/en not_active Abandoned
- 2000-04-14 WO PCT/JP2000/002456 patent/WO2000063388A1/ja active IP Right Grant
- 2000-04-14 CN CNB008088357A patent/CN100540668C/zh not_active Expired - Lifetime
- 2000-04-14 EP EP00917314A patent/EP1172437B1/en not_active Expired - Lifetime
-
2002
- 2002-05-29 HK HK02104011.5A patent/HK1042321B/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06261766A (ja) * | 1993-03-16 | 1994-09-20 | Mitsubishi Petrochem Co Ltd | フィードバックインヒビションの解除されたアスパルトキナーゼをコードする遺伝子dna及びその利用 |
Non-Patent Citations (1)
Title |
---|
KALINOWSKI J. ET AL.: "Genetic and biochemical analysis of the aspartkinase from Corynebacterium glutamicum", MOL. MICROBIOL., vol. 5, no. 5, 1991, pages 1197 - 1204, XP002929074 * |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7741460B2 (en) | 1999-12-30 | 2010-06-22 | Archer-Daniels-Midland Company | Polynucleotides encoding a truncated ORF2 from Corynebacterium |
US6927046B1 (en) | 1999-12-30 | 2005-08-09 | Archer-Daniels-Midland Company | Increased lysine production by gene amplification using coryneform bacteria |
US8067210B2 (en) | 1999-12-30 | 2011-11-29 | Hanke Paul D | Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacterium |
WO2003040373A3 (en) * | 2001-08-06 | 2003-12-18 | Degussa | Production of l-lysine by genetically modified corynebacterium glutamicum strains |
US7160711B2 (en) | 2001-08-06 | 2007-01-09 | Degussa Ag | Coryneform bacteria which produce chemical compounds I |
WO2003040373A2 (en) * | 2001-08-06 | 2003-05-15 | Degussa Ag | Production of l-lysine by genetically modified corynebacterium glutamicum strains |
US20100255544A1 (en) * | 2001-08-06 | 2010-10-07 | Evonik Degussa Gmbh | Coryneform bacteria which produce chemical compounds ii |
US7083942B2 (en) | 2002-03-09 | 2006-08-01 | Degussa Ag | Alleles of the aceA gene from coryneform bacteria |
US7566557B2 (en) | 2003-12-18 | 2009-07-28 | Paik Kwang Industrial Co., Ltd. | Gene variants coding for proteins from the metabolic pathway of fine chemicals |
WO2007063866A1 (ja) | 2005-11-29 | 2007-06-07 | Kyowa Hakko Kogyo Co., Ltd. | 新規蛋白質および該蛋白質をコードするdna |
US8058037B2 (en) | 2005-11-29 | 2011-11-15 | Kyowa Hakko Bio Co., Ltd. | Protein and DNA encoding the protein |
WO2007074857A1 (ja) | 2005-12-27 | 2007-07-05 | Kyowa Hakko Kogyo Co., Ltd. | L-グルタミンの製造法 |
JP2009531042A (ja) * | 2006-03-30 | 2009-09-03 | ビーエーエスエフ ソシエタス・ヨーロピア | カダベリンの生産方法 |
JP2013146269A (ja) * | 2006-03-30 | 2013-08-01 | Basf Se | カダベリンの生産方法 |
US8202706B2 (en) | 2006-07-13 | 2012-06-19 | Evonik Degussa Gmbh | Method of production of L-amino acids |
EP2612915A1 (en) | 2006-09-01 | 2013-07-10 | Kyowa Hakko Bio Co., Ltd. | Method for production of L-Glutamine |
JP2011510642A (ja) * | 2008-02-04 | 2011-04-07 | ビーエーエスエフ ソシエタス・ヨーロピア | ジピコリネートの産生方法 |
AU2009211870B2 (en) * | 2008-02-04 | 2013-09-05 | Basf Se | Method for the production of dipicolinate |
DE102008001874A1 (de) | 2008-05-20 | 2009-11-26 | Evonik Degussa Gmbh | Verfahren zur Herstellung von L-Aminosäuren |
WO2010005099A1 (ja) | 2008-07-09 | 2010-01-14 | 味の素株式会社 | アミノヒドロキシ安息香酸類の製造方法 |
JP2009284905A (ja) * | 2009-06-26 | 2009-12-10 | Toray Ind Inc | カダベリン発酵コリネ型細菌を用いたポリアミドの製造方法 |
WO2011073278A1 (en) | 2009-12-17 | 2011-06-23 | Basf Se | Processes and recombinant microorganisms for the production of cadaverine |
DE112010004851T5 (de) | 2009-12-17 | 2012-09-20 | Basf Se | Verfahren und rekombinante Mikroorganismen für die Herstellung von Cadaverin |
US9745608B2 (en) | 2011-02-22 | 2017-08-29 | Basf Se | Processes and recombinant microorganisms for the production of cadaverine |
WO2012114256A1 (en) | 2011-02-22 | 2012-08-30 | Basf Se | Processes and recombinant microorganisms for the production of cadaverine |
DE102011118019A1 (de) | 2011-06-28 | 2013-01-03 | Evonik Degussa Gmbh | Varianten des Promotors des für die Glyzerinaldehyd-3-phosphat-Dehydrogenase kodierenden gap-Gens |
WO2013000827A1 (de) | 2011-06-28 | 2013-01-03 | Evonik Degussa Gmbh | Varianten des promotors des für die glyzerinaldehyd-3-phosphat-dehydrogenase kodierenden gap-gens |
WO2013179711A1 (ja) | 2012-05-29 | 2013-12-05 | 味の素株式会社 | 3-アセチルアミノ-4-ヒドロキシ安息香酸の製造方法 |
EP2940144A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Lysin unter Verwendung eines alkaliphilen Bakteriums |
EP2940143A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Aminosäuren unter Verwendung eines alkaliphilen Bakteriums |
EP2940039A1 (de) | 2014-04-30 | 2015-11-04 | Evonik Degussa GmbH | Verfahren zur Produktion von L-Aminosäuren in Corynebakterien unter Verwendung eines Glycin spaltenden Systems |
DE102014208199A1 (de) | 2014-04-30 | 2015-11-05 | Evonik Degussa Gmbh | Verfahren zur Produktion von L-Aminosäuren unter Verwendung eines alkaliphilen Bakteriums |
Also Published As
Publication number | Publication date |
---|---|
EP1172437A1 (en) | 2002-01-16 |
JP4526710B2 (ja) | 2010-08-18 |
HK1042321A1 (en) | 2002-08-09 |
CN100540668C (zh) | 2009-09-16 |
KR100671785B1 (ko) | 2007-01-19 |
MXPA01010413A (es) | 2002-11-29 |
KR20020006539A (ko) | 2002-01-19 |
AU3837400A (en) | 2000-11-02 |
EP1172437A4 (en) | 2002-08-14 |
US6893848B1 (en) | 2005-05-17 |
HK1042321B (zh) | 2012-02-24 |
CN1355849A (zh) | 2002-06-26 |
EP1172437B1 (en) | 2011-05-25 |
ATE510917T1 (de) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000063388A1 (fr) | Nouvelle aspartokinase desensibilisee | |
JP4881739B2 (ja) | L−アルギニン、l−オルニチンまたはl−シトルリンの製造法 | |
US11555213B2 (en) | Nucleic acid encoding a modified homoserine dehydrogenase | |
US10961554B2 (en) | Promoter and a method for producing L-amino acid using the same | |
EP0931833A2 (en) | Method of producing L-serine fermentation | |
CN113046288B (zh) | 产生l-氨基酸的棒状杆菌属微生物和使用其生产l-氨基酸的方法 | |
KR102035844B1 (ko) | L-트립토판을 생산하는 재조합 코리네형 미생물 및 이를 이용한 l-트립토판을 생산하는 방법 | |
WO2007024010A1 (ja) | L−グルタミン酸生産菌及びl−グルタミン酸の製造方法 | |
WO1999007853A1 (fr) | Procede de production d'acide l-glutamique par fermentation | |
KR102344689B1 (ko) | L-발린 생산 미생물 및 이를 이용한 l-발린 생산 방법 | |
JP2024506841A (ja) | プレフェナート脱水酵素変異体及びそれを用いた分岐鎖アミノ酸生産方法 | |
AU2018353929B2 (en) | Microorganism of genus Corynebacterium producing L-arginine and method for producing L-arginine using the same | |
CN115003806A (zh) | 新atp磷酸核糖基转移酶变体及使用其生产l-缬氨酸的方法 | |
CN116157524B (zh) | 新型谷氨酰胺-水解gmp合酶变体和用于使用其生产嘌呤核苷酸的方法 | |
KR102419166B1 (ko) | 신규한 글루타민 가수분해 gmp 합성효소 변이체 및 이를 이용한 퓨린 뉴클레오티드의 생산방법 | |
RU2804010C1 (ru) | Новый вариант гидролизующей глутамин GMP-синтазы и способ получения пуринового нуклеотида с его использованием | |
CN115052976B (zh) | 新型乙酰羟酸合酶变体和包括其的微生物 | |
EP4310180A1 (en) | A microorganism of corynebacterium genus having enhanced l-arginine or l-citrulline productivity and a method for producing l-arginine or l-citrulline using the same | |
JP2000232890A (ja) | 発酵法によるl−グルタミン酸の製造法 | |
AU2021423180A1 (en) | aroG aldolase variant and method for producing branched chain amino acid by using same | |
KR20220156323A (ko) | Agl 단백질의 활성이 강화된, 아미노산을 생산하는 미생물 및 이를 이용한 아미노산 생산 방법 | |
CN115003688A (zh) | 新蛋白变体及使用其生产l-缬氨酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00808835.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2000 612467 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/010413 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017013302 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000917314 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000917314 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017013302 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09958606 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020017013302 Country of ref document: KR |